
Blog
Neuroscience Clinical Trials Round-Up: July 2020
by Mini Gill
Find out about the new and ongoing neuroscience clinical trials at Pacific Neuroscience Institute, addressing difficult diseases such as brain tumors.
When a Good Protein Goes Bad: Cdk5’s Role in Neurodegenerative Disease
by Guest Author
Neurodegenerative disease is a broad term for a range of conditions which mostly affect neurons in the human brain. Currently, 5 million Americans suffer from Alzheimer's disease; 1 million from Parkinson's disease; and 30,000 from Huntington's disease.
Music and Art Therapies May Help Alzheimer’s Patients
by Jennifer Bramen
Creative activities are powerful tools for promoting brain health in all people. They reduce stress, build emotional resilience, and provide healthy brain stimulation. All together, activities like playing music, painting, drawing, and building things will help promote a sharper, happier mind at all ages. Creative...
Is There a Connection Between Menopause and Alzheimer’s Disease?
by Jack Hodes
A gender disparity exists in the disproportionate number of women diagnosed with Alzheimer’s disease (AD) dementia. Data indicate that almost two-thirds of individuals living with AD in the United States are women.
Here We Grow Again – Expanding Brain Health Services in Southern California
by Zara Jethani
Pacific Brain Health Center expands to provide necessary services for more patients.
Business Minds Meet Medicine Minds in Annual YPO Event
by Zara Jethani
In February 2020, founder and CEO of Ring, Jamie Siminoff, invited Dr. Santosh Kesari, to speak to top business influencers at a YPO event held in Los Angeles to discuss modern advances in medicine including early detection and prevention of cancer and other neurological diseases, precision medicine,...
Dietary Flavonols Can Reduce the Risk of Alzheimer’s Disease Dementia
by Sarah McEwen, PhD
Featured in the Santa Monica Star, Dr. Sarah McEwen discusses results of a study examining the positive effects of flavonols and Alzheimer’s disease dementia.
Pacific Brain Health Center: Seeking A Cure For Alzheimer’s Disease
by Zara Jethani
Pacific Neuroscience Institute brain health specialists are striving to find a cure for Alzheimer's disease, which is the most common type of dementia. In the United States, about 5.5 million people are affected by Alzheimer's disease, and the worldwide prevalence is estimated to be as high as 24 million. Watch this video to find out about research and clinical trials at the Pacific Brain Health Center at PNI.
Clinical Trials Round Up: January 2020
by Mini Gill
Pacific Neuroscience Institute has a strong roster of clinical trials for a number of neurological conditions including brain tumor, Cushing's disease and Lewy bodies dementia. Find out more.
A New Drug May Help Reduce Delusions for People with Alzheimer’s
by Verna Porter
Dr. Verna R. Porter, MD, neurologist and director of dementia, Alzheimer’s disease, and neurocognitive disorders at Pacific Neuroscience Institute provides insightful information for those caring for loved ones with dementia and delusions. Read this Healthline news article about a new drug found to help reduce...
Last updated: March 23rd, 2020